Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Trading Statement

8 Nov 2021 07:00

RNS Number : 5723R
Kingspan Group PLC
08 November 2021
 

Kingspan Group Plc

Trading Update

 

8 November 2021

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, today issues a Trading Update for the period to 30 September 2021.

Sales in the nine month period to 30 September were €4.72bn, up 44% on the same period in the prior year, with sales growth of 50% in the third quarter. Underlying sales (pre currency and acquisitions) were up 34% in the year to date and by 33% in the third quarter.

 

Insulated Panels sales increased by 47% in the first nine months and by 53% in the third quarter. Underlying sales were up 42% year to date and up 43% in the third quarter. The sales performance across each of the Group's key markets has evidently been strong both year to date and in the quarter. Raw material inflation has been extraordinary, with the associated recovery and the top line boosted further by buoyant volume growth overall year to date. Notably, however, order intake in the months of August and September was lower than in the same two month period last year and this trend has continued in the weeks since. The TeraSteel acquisition completed earlier in the year is performing strongly. Overall, the global Insulated Panels backlog was up 49% in volume as at 30 September versus the same point last year.

 

Insulation Boards sales in the first nine months were up 51% and up 78% in the third quarter. Underlying sales were up 32% in the year to date and by 25% in the third quarter. Sales volumes overall were in line with the third quarter of 2020 with the top line reflecting mainly the higher cost of raw materials year on year. Sales in Central and Eastern Europe, the Nordics and North America were particular highlights in the third quarter although all key markets performed well. Recent investments, such as our Kooltherm® line in Sweden have been key in driving structural adoption to high performance insulation with further developments to come globally in 2022 and 2023. The Logstor acquisition, which completed in June, is integrating fully to plan.

 

Light & Air sales in the first nine months were up 28% in the year to date and by 12% in the third quarter. Underlying sales were up 1% year to date and were level in the third quarter. Market activity both in Europe and North America has been more subdued than in other categories. The division has prioritised the integration of acquisitions made in the current and prior year and achieving category scale. 2021 is shaping up to be a further year of progress in that context.

 

Data & Flooring sales in the first nine months were up 22% and up 21% in the third quarter. Underlying sales were up by 23% in the first nine months and were up 20% in the third quarter. Datacentre demand globally is robust, offsetting a weaker office market.

 

Water & Energy sales in the first nine months increased by 32% and up 24% in the third quarter. Underlying sales were up 18% year to date and by 8% in the third quarter. The waste water and rainwater harvesting categories continue to perform well.

 

Net debt at the end of September 2021 was €636m with a cumulative acquisition spend year to date of €485m and organic capital investment of €119m.

 

Looking ahead our backlog is strong although is reducing week on week as sales activity outpaces new order placement. Underlying panels order intake volume is down 10% in the third quarter versus the same period in 2020. 2021 so far has been unusual and characterised by order placement earlier in the year than is typical as customers sought to get ahead of ongoing inflation and availability pressures. It is likely what we are experiencing now is a fallow period in order placement following that. Raw material prices have been somewhat stable in more recent weeks, albeit at record high levels and following a period of unparalleled increases. There are no signs yet of any meaningful raw materials deflation although should that come the impact would be negative. We are acutely conscious of that.

 

The activity pipeline is generally encouraging particularly in large scale logistics, data, technology and the EV automotive sectors. These applications demand high energy efficient solutions, not just on day one but over the lifetime of the building, with Kingspan technology well placed in that environment. 2021 has still to play out fully with the seasonally important fourth quarter remaining and, accordingly, we expect to deliver a full year trading profit in the region of €750m, significantly ahead of the €508.2m recorded in 2020.

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVDLFBFFLZFBB
Date   Source Headline
4th May 20074:34 pmRNSDirector/PDMR Shareholding
30th Apr 20074:53 pmRNSVoting Rights and Capital
27th Mar 20072:01 pmRNSAnnual Update Amended
23rd Mar 200712:38 pmRNSAnnual Information Update
15th Mar 20074:11 pmRNSDirector/PDMR Shareholding
5th Mar 20077:02 amRNSFinal Results
11th Jan 200712:31 pmRNSVoting Rights and Capital
22nd Dec 200611:04 amRNSVoting Rights and Capital
22nd Dec 200611:01 amRNSDirector/PDMR Shareholding
18th Dec 20067:01 amRNSTrading Statement
28th Nov 20063:00 pmRNSTrading Update Notification
6th Nov 20063:43 pmRNSAcquisition Update
26th Oct 200611:19 amRNSAcquisition Update
19th Sep 20064:56 pmRNSDirector/PDMR Shareholding
6th Sep 200610:00 amRNSDirector/PDMR Shareholding
5th Sep 20067:02 amRNSInterim Results
4th Jul 20062:00 pmRNSAmended Blocklisting Return
4th Jul 20062:00 pmRNSDirector/PDMR Shareholding
3rd Jul 20069:00 amRNSBlocklisting Interim Review
26th Jun 200610:05 amRNSAcquisition
19th Jun 200610:20 amRNSDirector/PDMR Shareholding
14th Jun 20063:10 pmRNSDirector/PDMR Shareholding
9th Jun 20067:00 amRNSAnalyst Site Visit
1st Jun 20062:07 pmRNSDirector/PDMR Shareholding
26th May 20062:31 pmRNSDirector/PDMR Shareholding
25th May 200612:53 pmRNSAGM Results
25th May 20067:00 amRNSAGM Statement
23rd May 20065:02 pmRNSChairmanStatementNotification
9th May 20067:01 amRNSStatement re Press Comment
3rd May 200610:52 amRNSDirector/PDMR Shareholding
11th Apr 20064:38 pmRNSDirector/PDMR Shareholding
31st Mar 20064:52 pmRNSAnnual Information Update
30th Mar 20065:04 pmRNSHolding(s) in Company
16th Mar 20065:28 pmRNSDirector/PDMR Shareholding
6th Mar 20067:01 amRNSFinal Results
15th Feb 200611:32 amRNSHolding(s) in Company
10th Feb 20065:12 pmRNSHolding(s) in Company
31st Jan 200611:13 amRNSBlocklisting Review
3rd Jan 20067:01 amRNSDirectorate Change
21st Dec 20059:51 amRNSUp-date Analyst's Call
7th Dec 20059:45 amRNSTrading Statement Notificatio
29th Nov 20054:37 pmRNSBlock Listing Application
28th Nov 200510:49 amRNSSIXTYK Housing Award
18th Nov 20055:21 pmRNSDirector/PDMR Shareholding
28th Oct 20053:46 pmRNSDirector/PDMR Shareholding
27th Oct 20055:04 pmRNSHolding(s) in Company
21st Oct 20057:01 amRNSAward Win
11th Oct 20054:17 pmRNSDirector/PDMR Shareholding
4th Oct 20052:46 pmRNSDirector/PDMR Shareholding
28th Sep 20053:40 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.